Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
deals
3
×
glaxosmithkline
3
×
life sciences
national blog main
national top stories
startups
3
×
clinical trials
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
abbvie
adalimumab (humira)
aducanumab
aduro biotech
affordable care act
alez azar
allosteric
alnylam pharmaceuticals
alzheimer's disease
antibiotics
atlas venture
atopic dermatitis
autoimmune disorders
axial spondyloarthritis
bausch health
beijing
biogen
boston
boston university
boulder/denver blog main
boulder/denver top stories
brace pharma
brii bio
brii biosciences
bristol-myers squibb
cancer
cancer immunotherapy
What
new
3
×
adds
disease
drug
earlier
medicines
address
ago
alliance
allosteric
approval
areas
bio
biogen’s
biopharmaceutical
biosciences
bio’s
brii
clinic
companies
convo
elusive
failures
hepatitis
hotspot
infectious
launched
littered
million
mission
molecules
nash
news
path
pipeline
potential
price
remains
road
roundup
Language
unset
Current search:
glaxosmithkline
×
startups
×
new
×
deals
×
@xconomy.com
4 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline